Introduction: Acute bronchiolitis is the most common cause of hospitalization among infants. Although
antibiotics are not recommended in the absence of secondary bacterial infection, rates of antibiotic
usage is high rate in clinical practices
Objectives: To test the hypothesis that clarithromycin use in infants with acute viral bronchiolitis shortens
length of hospital stay.
Materials and Methods: One hundred sixty-seven patients aged 1-24 months hospitalized for treatment
with a diagnosis of acute viral bronchiolitis at pediatric clinic between April 2017 and May 2018 were
investigated retrospectively. The patients were divided into two separate groups, Group A (122 patients),
using clarithromycin therapy during hospitalization, and Group B (45 patients), which did not receive
clarithromycin (Group B). Demographic and clinical data, treatments received, and duration of hospital
stay were obtained from patients’ records.
Results: The rate of clarithromycin use in this study was 73%. No statistically significant difference in
length of hospital stay was determined between patients receiving clarithromycin and those receiving no
antibiotic therapy. However, length of hospital stay decreased with age. Clarithromycin use elicited no
statistically significant decrease in hospital stay in patients with acute viral bronchiolitis.
Conclusions: The routine use of clarithromycin is not recommended in acute viral bronchiolitis in the
light of its cost and side-effects, and the fact is has no impact on clinical status and hospital stay